Bone densitometry developer CompuMed reported a slight increase in revenues as well as a reduction in its net loss for its first fiscal quarter of 2004.
The Los Angeles-based company reported revenues of $460,000 for the period (end-December 31, 2003) compared with revenues of $452,000 for the same period the previous year. Net loss for the quarter was $61,000, a reduction of 60% compared with a net loss of $147,000 for the same quarter of fiscal 2003.
The firm said that although revenues in its electrocardiogram product line were down, its OsteoGram sales rose by 314%, with much of this business coming from Asia, where CompuMed has focused its distribution-related efforts over the past year.
By AuntMinnie.com staff writersFebruary 17, 2004
Related Reading
CompuMed signs for credit line, January 12, 2004
CompuMed sales edge lower, December 30, 2003
Orex to license CompuMed OsteoGram software, November 5, 2003
CompuMed inks deal with NIR, October 28, 2003
CompuMed, Medstrat set partnership, October 21, 2003
Copyright © 2004 AuntMinnie.com
